From Surf Wiki (app.surf) — the open knowledge base
Gapicomine
Chemical compound
Chemical compound
| elimination_half-life =
Gapicomine (INN) is a coronary vasodilator. It has been withdrawn from the market in the countries it was used in.
Also, gapicomine is a major component in the drug Bicordin.
History
Gapicomine was discovered in 1970 by Polish chemist Stanisław Biniecki. It was first published about in an article of The Polish Journal of Medicine and Pharmacy describing the derivative drug Bicordin in 1974.
Synthesis
The oxime formation between isonicotinaldehyde [872-85-5] (1) and hydroxylamine gives 4-Pyridinealdoxime [696-54-8] (2). This is then reduced by catalytic hydrogenation over Raney-Nickel into 4-Picolylamine [3731-53-1] (3). Reductive amination of the last with a second equivalent of isonicotinaldehyde affords gapicomine (4).
References
References
- "Gapicomine Monograph, The Index Nominum".
- "Bicordin, PubChem".
- (1974). "Bicordin--a new drug in the treatment of coronary heart disease.". Mater Med Pol..
- Anon., {{Cite patent. GB. 1058356 (1967 to Starogardzkie Zakl Farma).
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Gapicomine — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report